FDA asks Pharma company to remove powerful painkiller from the market

The U.S. Nourishment and Drug Administration has asked the organization Endo Pharmaceuticals to expel one of its medications from the market due to its high potential for manhandle.

Opana E-R is a capable painkiller that the organization says is being pounded up and infused by individuals looking to mishandle it.

This is the first run through the FDA has made such move, however they say the dangers of the medication exceed the advantages.

Endo Pharmaceuticals says the medication is protected and compelling.

The organization discharged an announcement saying they are "checking on the demand" and they are "assessing the full scope of potential alternatives" to "decide the suitable way ahead."